ascendis pharma glp-1 Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug 1 Support helps support appetite control Novo Nordisk, Ascendis Ink $285M
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14







)















